Skip to main content
SpringerLink
Log in

Without Extrapolation, Cmax/AUC is an Effective Metric in Investigations of Bioequivalence

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. F. Y. Bois, T. N. Tozer, W. W. Hauck, M. L. Chen, R. Patnaik, and R. L. Williams. Bioequivalence: performance of several measures of extent of absorption. Pharm. Res. 11:715–722 (1994).

    Google Scholar 

  2. F. Y. Bois, T. N. Tozer, W. W. Hauck, M. L. Chen, R. Patnaik, and R. L. Williams. Bioequivalence: performance of several measures of rate of absorption. Pharm. Res. 11:966–974 (1994).

    Google Scholar 

  3. A. C. Cartwright, U. Gundert-Remy, G. Rauws, I. McGilveray, T. Salmonson, S. Walters. International harmonization and consensus DIA meeting on bioavailability and bioequivalence testing requirements and standards. Drug Information J. 25:471–482 (1991).

    Google Scholar 

  4. L. Endrenyi, L. Tothfalusi, and J. Zha. Metrics assessing absorption rates: principles, and determination of bioequivalence in the steady state. In K. K. Midha and H. H. Blume (eds), Biolnternational '94:Bioavailability, Bioequivalence and Pharmacokinetics, 1995, in press.

  5. L. Endrenyi, S. Fritsch, and W. Yan. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:394–399 (1991).

    Google Scholar 

  6. R. Schall, and H. E. Luus. Comparison of absorption rates in bioequivalence studies of immediate release drug formulations. Int. J. Clin. Pharmacol. Ther. Toxicol. 30:153–159 (1992).

    Google Scholar 

  7. L. F. Lacey, O. N. Keene, C. Duquesnoy, and A. Bye. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. J. Pharm. Sci. 83:212–215 (1994).

    Google Scholar 

  8. L. Endrenyi, and W. Yan. Variation of Cmax and Cmax/AUC in investigations of bioequivalence. Int. J. Clin Pharmacol. Ther. Toxicol. 31:184–189 (1993).

    Google Scholar 

  9. K. K. Midha, J. W. Hubbard, M. Rawson, and L. Gavalas. The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: experimental evidence. Eur. J. Pharm. Sci. 2:351–363 (1994).

    Google Scholar 

  10. D. J. Schuirmann. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 15:657–680 (1987).

    Google Scholar 

  11. L. Endrenyi, S. Fritsch, and Y. Wei. Some kinetic and statistical considerations on the evaluation of comparative absorption rates. In I. J. McGilveray, S. V. Dighe, I. W. French, K. K. Midha and J. P. Skelly (eds), Issues in the Evaluation of Bioavailability Data, BioInternational '89, Toronto, 1990, pp. 43–48.

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, and Department of Preventive Medicine and Biostatistics, University of Toronto, Toronto, Ontario, M5S 1A8

    Laszlo Tothfalusi & Laszlo Endrenyi

Authors
  1. Laszlo Tothfalusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laszlo Endrenyi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tothfalusi, L., Endrenyi, L. Without Extrapolation, Cmax/AUC is an Effective Metric in Investigations of Bioequivalence. Pharm Res 12, 937–942 (1995). https://doi.org/10.1023/A:1016237826520

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016237826520

Search

Navigation